| Cvs Pharmacy #17633 | |
| 12725 W Bluemound Rd, Brookfield, Wisconsin 53005 | |
| (262) 395-1626 |
| Name | Cvs Pharmacy #17633 |
|---|---|
| Organization Name | Wisconsin Cvs Pharmacy Llc |
| Location | 12725 W Bluemound Rd, Brookfield, Wisconsin 53005 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (262) 395-1626 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Minneapolis Heart Institute Foundation research cardiologist Dr. Michael Miedema is the lead author of a paper published by Circulation - Cardiovascular Imaging, a journal of the American Heart Association, that suggests a connection between an adult's height and the prevalence of coronary artery calcium (CAC), a direct marker of plaque in the arteries that feed the heart.
Whether you have an increased risk of developing type 2 diabetes, in the future may be derived from the composition of your intestinal flora. That according to new metagenomics research of an international consortium of scientists, including Jeroen Raes, connected to VIB and Vrije Universiteit Brussel. Metagenomics is the study of the genetic material of complete ecosystems, in this case the human intestine. This study appears in the leading journal Nature.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.
› Verified 8 days ago
| NPI Number | 1225398738 |
| Organization Name | WISCONSIN CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY #17633 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 12725 W Bluemound Rd, Brookfield, WI 53005 |
| Phone Number | 262-395-1626 |
News Archive
Minneapolis Heart Institute Foundation research cardiologist Dr. Michael Miedema is the lead author of a paper published by Circulation - Cardiovascular Imaging, a journal of the American Heart Association, that suggests a connection between an adult's height and the prevalence of coronary artery calcium (CAC), a direct marker of plaque in the arteries that feed the heart.
Whether you have an increased risk of developing type 2 diabetes, in the future may be derived from the composition of your intestinal flora. That according to new metagenomics research of an international consortium of scientists, including Jeroen Raes, connected to VIB and Vrije Universiteit Brussel. Metagenomics is the study of the genetic material of complete ecosystems, in this case the human intestine. This study appears in the leading journal Nature.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.
› Verified 8 days ago
News Archive
Minneapolis Heart Institute Foundation research cardiologist Dr. Michael Miedema is the lead author of a paper published by Circulation - Cardiovascular Imaging, a journal of the American Heart Association, that suggests a connection between an adult's height and the prevalence of coronary artery calcium (CAC), a direct marker of plaque in the arteries that feed the heart.
Whether you have an increased risk of developing type 2 diabetes, in the future may be derived from the composition of your intestinal flora. That according to new metagenomics research of an international consortium of scientists, including Jeroen Raes, connected to VIB and Vrije Universiteit Brussel. Metagenomics is the study of the genetic material of complete ecosystems, in this case the human intestine. This study appears in the leading journal Nature.
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it priced a public offering of 5,000,000 shares of its common stock at $1.35 per share. Net proceeds from the offering, after underwriting discounts and commissions and expenses, will be approximately $5,697,500. NeoStem has granted the underwriters an option to purchase up to an additional 750,000 shares to cover over-allotments, if any.
Allos Therapeutics, Inc. announced today that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTCL). The Company is currently investigating pralatrexate in a Phase 1 clinical study in patients with relapsed or refractory CTCL.
Coronaviruses are adept at imitating human immune proteins that have been implicated in severe COVID-19 disease, a study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found.
› Verified 8 days ago
Aurora Pharmacy Type: Clinic Pharmacy Location: 16985 West Bluemound Road, Brookfield, Wisconsin 53005 Phone: (262) 782-8125 | |
Eye Prosthetics Of Wisconsin Inc Type: Medicare Supplier Location: 13255 W Bluemound Rd, Brookfield, Wisconsin 53005 Phone: (262) 754-3681 | |
Healthdirect Institutional Pharmacy Type: Community/Retail Pharmacy Location: 150 N Patrick Blvd, Brookfield, Wisconsin 53045 Phone: (262) 395-4658 | |
Incontrol Medical, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3225 Gateway Rd, Brookfield, Wisconsin 53045 Phone: (262) 373-0422 | |
Lenscrafters #0032 Type: Eyewear Supplier (Equipment, not the service) Location: 16970a W Bluemound Rd, Brookfield, Wisconsin 53005 Phone: (262) 784-8120 |